Orchid Pharma Ltd - 524372 - Appointment of Company Secretary and Compliance Officer
Intimation of appointment of Company Secretary and Compliance Officer06-03-2020
06-03-2020
Orchid Pharma Ltd - 524372 - Corporate Insolvency Resolution Process (CIRP)-Updates - Corporate Insolvency Resolution Process (CIRP)
Corporate Insolvency Resolution Process-Updates03-03-2020
Orchid Pharma Ltd - 524372 - Outcome Of Meeting - Approval Of Unaudited Financial Results For The Quarter Ended December 31, 2019
In accordance with Regulation 33 of SEBI (Listing Obligations & Disclosure Requirements) Regulations 2015, we would like to inform that the Resolution Professional at a meeting held on February 17, 2020 has considered and approved the Unaudited Financial Results (both Standalone and Consolidated) of the Company for the Quarter (Q3 of FY 2019-20) ended December 31, 2019. A copy of the Unaudited Financial Results along with the Limited Review Report issued by the Statutory Auditors is enclosed.17-02-2020
Orchid Pharma Ltd - 524372 - Board Meeting Intimation for Unaudited Financial Results For The Quarter Ended December 31, 2019
Orchid Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 17/02/2020 ,inter alia, to consider and approve Pursuant to Regulation 29 and other applicable provisions of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Resolution Professional shall hold a Meeting on Monday, February 17, 2020, inter alia, to consider and approve the Unaudited Financial Results of the Company for the quarter ended December 31, 2019.11-02-2020
Orchid Pharma Ltd - 524372 - Shareholding for the Period Ended December 31, 2019
Orchid Pharma Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2019. For more details, kindly Click here20-01-2020
Orchid Pharma Ltd - 524372 - Statement Of Investor Complaints For The Quarter Ended December 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0220 Name of the Signatory :- Shri S ManiDesignation :- Authorised Signatory14-01-2020
Orchid Pharma Ltd - 524372 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Orchid Pharma Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here01-01-2020
NCLT dissolves Orchid Pharma's promoter firm, says no gain for shareholders
CoC says parent firm has no assets other than holding in Orchid Pharma, which itself is undergoing CIRP; Even if there is a resolution for Orchid Pharma, nothing would be left for investors31-12-2019
Orchid Pharma Ltd - 524372 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Scrutinizer's Report on the Voting Results of 26th Annual General Meeting31-12-2019
Orchid Pharma Ltd - 524372 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Proceedings of 26th AGM31-12-2019